For research use only. Not for therapeutic Use.
Dacisteine (N,S-Diacetyl-L-cysteine) is a cysteine derivative and displays a less New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitor with an IC50 value of 1000 μM[1]. Dacisteine can be used for the treatment of cardiovascular and cerebrovascular diseases caused by platelet aggregation[2].
Dacisteine is a preparing agent for treating or preventing cardiovascular and cerebrovascular diseases caused by platelet aggregation.
| Catalog Number | R046397 |
| CAS Number | 18725-37-6 |
| Synonyms | (2R)-2-acetamido-3-acetylsulfanylpropanoic acid |
| Molecular Formula | C7H11NO4S |
| Purity | ≥95% |
| InChI | InChI=1S/C7H11NO4S/c1-4(9)8-6(7(11)12)3-13-5(2)10/h6H,3H2,1-2H3,(H,8,9)(H,11,12)/t6-/m0/s1 |
| InChIKey | HSPYGHDTVQJUDE-LURJTMIESA-N |
| SMILES | CC(=O)NC(CSC(=O)C)C(=O)O |
| Reference | [1]. Cui-Gai Bai1, et al. Cysteine and Its Derivatives as New Delhi Metallo-beta-lactamase-1 Inhibitors. Current Enzyme Inhibition, 2015, 11, 46-57 [2]. FanKe, et al.Application of compound of thioether acid structure in preparing anti-platelet aggregation drugs. Patent WO2019007015A1. |
